insights_auto
Why is BOT down २०.००%?
Dive Deeperchevron_right
BOT:ASX
Botanix Pharmaceuticals Ltd
A$ ०.००८०
arrow_downward
-२०.००%(-०.००२०) 1D
नोभेम्बर २०, १६:१०:०७ GMT+११ · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BOT...
Open
A$ ०.०१
High
A$ ०.०१
Low
A$ ०.०१
Mkt. cap
२.२१ करोड
Avg. vol.
१.११ करोड
Volume
८५.९६ लाख
52-wk high
A$ ०.१५
52-wk low
A$ ०.०१
EPS
-A$ ०.०३
Shares outstanding
२.७६ अरब
No. of employees
११
Open
A$ ०.०१
High
A$ ०.०१
Low
A$ ०.०१
Mkt. cap
२.२१ करोड
Avg. vol.
१.११ करोड
Volume
८५.९६ लाख
52-wk high
A$ ०.१५
52-wk low
A$ ०.०१
EPS
-A$ ०.०३
Shares outstanding
२.७६ अरब
No. of employees
११
News stories
From web sources and news partners
Traders Union
·
१ घण्टा पहिले
VIX fear index hits highest level since April 2025 as S&P 500 plunges
Nacionale
·
५ घण्टा पहिले
Is the stock market down for the year? Only the Nasdaq; the S&P 500 and Dow are barely up for 2026
FXStreet
·
११ घण्टा पहिले
Dow Jones Industrial Average drops for a fifth day as AI rout widens
Big News Network.com
·
४२ मिनेट पहिले
S&P 500 earnings growth projected to slow to 11% in 2027 as AI investment impulse peaks: Goldman Sachs
Profile
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company's lead product is Sofdra, which treats axillary hyperhidrosis. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
About Botanix Pharmaceuticals Ltd